These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 18158470)
1. New pharmacologic therapies for acute heart failure. Tavares M; Rezlan E; Vostroknoutova I; Khouadja H; Mebazaa A Crit Care Med; 2008 Jan; 36(1 Suppl):S112-20. PubMed ID: 18158470 [TBL] [Abstract][Full Text] [Related]
2. Pharmacology of new agents for acute heart failure syndromes. Gheorghiade M; Teerlink JR; Mebazaa A Am J Cardiol; 2005 Sep; 96(6A):68G-73G. PubMed ID: 16181825 [TBL] [Abstract][Full Text] [Related]
3. Inotropes in the management of acute heart failure. Petersen JW; Felker GM Crit Care Med; 2008 Jan; 36(1 Suppl):S106-11. PubMed ID: 18158469 [TBL] [Abstract][Full Text] [Related]
4. Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure. Earl GL; Fitzpatrick JT Ann Pharmacother; 2005 Nov; 39(11):1888-96. PubMed ID: 16219899 [TBL] [Abstract][Full Text] [Related]
5. The development of new medical treatments for acute decompensated heart failure. Teerlink JR Heart Fail Monit; 2002; 2(4):129-37. PubMed ID: 12634887 [TBL] [Abstract][Full Text] [Related]
9. Is calcium sensitization the best strategy to improve myocardial contractility in acute heart failure? Erhardt LR Ital Heart J; 2003 May; 4 Suppl 2():27S-33S. PubMed ID: 14635367 [TBL] [Abstract][Full Text] [Related]
10. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone. Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729 [TBL] [Abstract][Full Text] [Related]
11. Levosimendan: a new approach for the treatment of patients with severe heart failure. A brief summary based on a clinical case. Morais J; Dias B; Pontes N Rev Port Cardiol; 2003; 22(7-8):941-8. PubMed ID: 14587161 [TBL] [Abstract][Full Text] [Related]
12. The utility of levosimendan in the treatment of heart failure. Lehtonen L; Põder P Ann Med; 2007; 39(1):2-17. PubMed ID: 17364447 [TBL] [Abstract][Full Text] [Related]
13. Newer approaches to the pharmacological management of heart failure. Rauch H; Motsch J; Böttiger BW Curr Opin Anaesthesiol; 2006 Feb; 19(1):75-81. PubMed ID: 16547437 [TBL] [Abstract][Full Text] [Related]
14. Overview of emerging pharmacologic agents for acute heart failure syndromes. De Luca L; Mebazaa A; Filippatos G; Parissis JT; Böhm M; Voors AA; Nieminen M; Zannad F; Rhodes A; El-Banayosy A; Dickstein K; Gheorghiade M Eur J Heart Fail; 2008 Feb; 10(2):201-13. PubMed ID: 18279775 [TBL] [Abstract][Full Text] [Related]
15. Levosimendan: a new option in acute septic cardiac failure? Powell BP; De Keulenaer B Emerg Med Australas; 2007 Apr; 19(2):177; author reply 177-8. PubMed ID: 17448109 [No Abstract] [Full Text] [Related]
16. Emerging therapies for the management of decompensated heart failure: from bench to bedside. deGoma EM; Vagelos RH; Fowler MB; Ashley EA J Am Coll Cardiol; 2006 Dec; 48(12):2397-409. PubMed ID: 17174176 [TBL] [Abstract][Full Text] [Related]
17. [Use of levosimendan in acute heart failure and its effect on renal function]. Moyano AP; Hidalgo RL; Grande DB; Morales SC Nefrologia; 2009; 29(6):616-7. PubMed ID: 19936016 [No Abstract] [Full Text] [Related]
18. Levosimendan: a new option in acute cardiac failure. Holley AD; Ziegenfuss M Emerg Med Australas; 2006; 18(5-6):505-9. PubMed ID: 17083641 [No Abstract] [Full Text] [Related]
19. Evidence-based use of levosimendan in different clinical settings. De Luca L; Colucci WS; Nieminen MS; Massie BM; Gheorghiade M Eur Heart J; 2006 Aug; 27(16):1908-20. PubMed ID: 16682381 [TBL] [Abstract][Full Text] [Related]